TY - JOUR
T1 - Metastatic colon cancer, version 3.2013
T2 - Featured updates to the NCCN guidelines
AU - Benson, Al B.
AU - Bekaii-Saab, Tanios
AU - Chan, Emily
AU - Chen, Yi Jen
AU - Choti, Michael A.
AU - Cooper, Harry S.
AU - Engstrom, Paul F.
AU - Enzinger, Peter C.
AU - Fakih, Marwan G.
AU - Fenton, Moon J.
AU - Fuchs, Charles S.
AU - Grem, Jean L.
AU - Hunt, Steven
AU - Kamel, Ahmed
AU - Leong, Lucille A.
AU - Lin, Edward
AU - May, Kilian Salerno
AU - Mulcahy, Mary F.
AU - Murphy, Kate
AU - Rohren, Eric
AU - Ryan, David P.
AU - Saltz, Leonard
AU - Sharma, Sunil
AU - Shibata, David
AU - Skibber, John M.
AU - Jr, William Small
AU - Sofocleous, Constantinos T.
AU - Venook, Alan P.
AU - Willett, Christopher G.
AU - Gregory, Kristina M.
AU - Freedman-Cass, Deborah A.
PY - 2013/2/1
Y1 - 2013/2/1
N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.
AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.
UR - http://www.scopus.com/inward/record.url?scp=84874641687&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2013.0022
DO - 10.6004/jnccn.2013.0022
M3 - Article
C2 - 23411381
AN - SCOPUS:84874641687
SN - 1540-1405
VL - 11
SP - 141
EP - 152
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 2
ER -